Understanding Your Child's 21-Day Cycle: An Introduction to Cyclic Neutropenia
At a Glance
Cyclic neutropenia causes a child’s neutrophil count to fall for about 3 to 5 days on a repeating 21-day cycle, then recover. Serial blood counts confirm the pattern, while low-count periods require attention to fever, infections, and mouth sores.
Receiving a diagnosis of cyclic neutropenia (CyN) can feel overwhelming, especially when you learn how rare it is. It is estimated to affect only about 0.5 to 1 person in every million [1]. This means your child is one of a very small group of people, and it is completely normal to feel a mix of relief at finally having an answer and anxiety about what this “ultra-rare” label means for your family’s future.
The 21-Day Rhythm
The hallmark of cyclic neutropenia is a predictable, repeating rise and fall in the number of neutrophils (a critical type of white blood cell that fights bacterial infections) [2]. Neutrophil levels are measured by an Absolute Neutrophil Count (ANC), typically reported as cells per microliter (cells/µL) or ×10⁹/L.
While most people have a steady supply of these cells, a child with CyN experiences a cycle that typically lasts about 21 days [3].
- The Nadir (The Low Point): For about 3 to 5 days out of every 21-day cycle, the Absolute Neutrophil Count (ANC) drops to very low levels [1][3]. This is when your child is most vulnerable to infections, mouth sores (oral ulcers), and fevers [4].
- The Recovery Phase: Between these low points, the neutrophil count rises, often reaching normal or near-normal levels [2]. During this time, your child’s defense against bacteria is much stronger, and they usually feel healthy and energetic.
The Biological “Oscillator”
Most cases of CyN are caused by a mutation in the ELANE gene [5]. This mutation can be inherited in an autosomal-dominant pattern from a parent (who might have mild or no symptoms), or it can arise for the first time in the child (de novo). This gene provides instructions for making an enzyme called neutrophil elastase, which is normally found inside neutrophils.
The 21-day cycle isn’t just a random event; leading scientific models suggest it’s a result of a biological feedback loop in the bone marrow involving hematopoietic stem cells (the “parent” cells that create all blood cells) [6]:
- Cellular Stress: In CyN, the mutated ELANE gene creates a version of the elastase enzyme that causes stress within the developing cells in the bone marrow, known as ER stress or the unfolded protein response (UPR) [6][7].
- Cell Loss: This stress is so severe that many developing neutrophils die before they can mature and enter the bloodstream. This leads to the “nadir” or low point in the blood count [8].
- The Comeback: As the neutrophil levels drop, the body sends out a powerful signal—a cytokine (growth factor) called G-CSF (Granulocyte Colony-Stimulating Factor)—to tell the bone marrow to make more cells [6].
- The Feedback Loop: Stem cells respond to this signal and begin production [9]. As these new neutrophils enter the blood, they eventually “turn off” the G-CSF signal, and the cycle begins to reset [9].
CyN vs. SCN: Understanding the Difference
You may hear your doctors mention Severe Congenital Neutropenia (SCN). While both CyN and SCN can be caused by ELANE mutations, they are different conditions [10]:
| Feature | Cyclic Neutropenia (CyN) | Severe Congenital Neutropenia (SCN) |
|---|---|---|
| Blood Count Pattern | Predictable cycles (usually 21 days) with recovery periods [2]. | Persistently low neutrophil counts with little to no recovery [2]. |
| Infection Risk | Primarily during the 3-5 day “nadir” [1]. | Constant risk of severe infection [2]. |
| Bone Marrow | Shows a “late-stage” slowdown in cell development [11]. | Shows “maturation arrest,” where cells stop developing very early [11]. |
| Long-term Outlook | Generally has a lower risk of evolving into more serious blood disorders compared to SCN [2]. | Requires closer monitoring for potential long-term bone marrow changes [2]. |
It is important to know that a genetic test showing an ELANE mutation cannot always tell the difference between CyN and SCN on its own [10]. Doctors distinguish between them by looking at your child’s blood counts over time—often by checking levels repeatedly—to see if that 21-day rhythm appears [12][3].
Living with the Cycle
Knowing the cycle exists is a powerful tool for parents. Instead of infections feeling like random, “bad luck” events, they become predictable windows that you can prepare for. Many families use a calendar to track the 21-day cycle, allowing them to anticipate the low points and take extra precautions. While the calendar is often more favorable for planning events or travel when confirmed by the care team, remember that infections can still occur outside the predicted nadir, and symptoms always take precedence.
While the “ultra-rare” nature of this condition can feel isolating, the predictability of the cycle often allows children with CyN to lead very full, active lives between their nadirs.
Common questions in this guide
What is cyclic neutropenia in children?
How is cyclic neutropenia different from severe congenital neutropenia?
What causes cyclic neutropenia?
How do doctors confirm the 21-day pattern?
What symptoms can happen during the low-count period?
Can children with cyclic neutropenia be active between low-count periods?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.What is my child's Absolute Neutrophil Count (ANC) during their lowest points (nadir), and how high does it go during the recovery phase?
- 2.Do we have enough serial blood counts over a 6-week period to confirm the 21-day cycle, or do we need more frequent testing?
- 3.Which specific ELANE mutation was identified, and is it one typically associated with a cyclic pattern?
- 4.How do my child’s bone marrow findings compare to the 'maturation arrest' typically seen in severe congenital neutropenia (SCN)?
- 5.What is our specific protocol for when my child develops a fever during a predicted 3-to-5-day low point?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (12)
- 1
Management of acute cholecystitis in patient with cyclic neutropenia: a case report.
Nishikawa S, Hamaoka M, Nakahara H, Itamoto T
Surgical case reports 2021; (7(1)):29 doi:10.1186/s40792-021-01117-7.
PMID: 33484365 - 2
Novel ELANE Mutation Associated with a Clinical Presentation of Cyclic Neutropenia.
Little KM, Conant JL, Devitt KA, Gardner JA
Journal of the Association of Genetic Technologists 2023; (49(4)):167-170.
PMID: 38049151 - 3
A case report of de novo ELANE c.416C>T mutation causing cyclic neutropenia in a 7-year-old girl.
Chen R, Xu Z, Zhang F
Frontiers in immunology 2026; (17()):1815284 doi:10.3389/fimmu.2026.1815284.
PMID: 42058194 - 4
Cyclic neutropenia with a novel gene mutation presenting with a necrotizing soft tissue infection and severe sepsis: case report.
Boo YJ, Nam MH, Lee EH, Lee KC
BMC pediatrics 2015; (15()):34 doi:10.1186/s12887-015-0352-5.
PMID: 25880377 - 5
Screening for ELANE, HAX1 and GFI1 gene mutations in children with neutropenia and clinical characterization of two novel mutations in ELANE gene.
Komvilaisak P, Yudhasompop N, Kanchanakamhaeng K, et al.
BMC pediatrics 2023; (23(1)):592 doi:10.1186/s12887-023-04428-w.
PMID: 37993852 - 6
New insights into the pathomechanism of cyclic neutropenia.
Mir P, Klimiankou M, Findik B, et al.
Annals of the New York Academy of Sciences 2020; (1466(1)):83-92 doi:10.1111/nyas.14309.
PMID: 32083314 - 7
ELANE mutant-specific activation of different UPR pathways in congenital neutropenia.
Nustede R, Klimiankou M, Klimenkova O, et al.
British journal of haematology 2016; (172(2)):219-27 doi:10.1111/bjh.13823.
PMID: 26567890 - 8
Mosaicism of an ELANE mutation in an asymptomatic mother in a familial case of cyclic neutropenia.
Hirata O, Okada S, Tsumura M, et al.
Journal of clinical immunology 2015; (35(5)):512-6 doi:10.1007/s10875-015-0165-1.
PMID: 25912133 - 9
Differential transcriptional control of hematopoiesis in congenital and cyclic neutropenia patients harboring ELANE mutations.
Zeidler A, Borbaran-Bravo N, Dannenmann B, et al.
Haematologica 2024; (109(5)):1393-1402 doi:10.3324/haematol.2023.284033.
PMID: 37855057 - 10
Genetic backgrounds and clinical characteristics of congenital neutropenias in Israel.
Yeshareem L, Yacobovich J, Lebel A, et al.
European journal of haematology 2024; (113(2)):146-162 doi:10.1111/ejh.14197.
PMID: 38600884 - 11
Impact of different genetic mutations on granulocyte development and G-CSF responsiveness in congenital neutropenia.
Meng X, Zhang H, Dong L, et al.
Blood advances 2024; (8(7)):1667-1682 doi:10.1182/bloodadvances.2023012171.
PMID: 38286463 - 12
Cyclic manner of neutropenia in a patient with HAX-1 mutation.
Cipe FE, Celiksoy MH, Erturk B, Aydogmus Ç
Pediatric hematology and oncology 2018; (35(3)):181-185 doi:10.1080/08880018.2018.1486489.
PMID: 30346863
This page is for informational purposes only and does not constitute medical advice. Ask your child's care team how to interpret blood counts and what to do if fever occurs during a low-count period.
Get notified when new evidence is published on Cyclic neutropenia.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.